HCA
TARS icon

Harbor Capital Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

Harbor Capital Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Buy
29,283
+7,561
+35% +$528K 0.17% 177
2025
Q4 		$1.78M Buy
21,722
+6,134
+39% +$458K 0.14% 198
2025
Q3 		$926K Sell
15,588
-8,679
-36% -$427K 0.07% 338
2025
Q2 		$983K Buy
24,267
+3,499
+17% +$157K 0.04% 437
2025
Q1 		$1.07M Sell
20,768
-1,345
-6% -$66.5K 0.05% 421
2024
Q4 		$1.22M Buy
22,113
+4,008
+22% +$182K 0.05% 414
2024
Q3 		$595K Buy
18,105
+6,612
+58% +$186K 0.03% 545
2024
Q2 		$312K Sell
11,493
-127
-1% -$4.27K 0.02% 601
2024
Q1 		$422K Buy
+11,620
New +$342K 0.06% 441

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return